HYTERA
24.5.2021 12:24:07 CEST | Business Wire | Press release
Hytera , as a world leading provider of professional communications technologies and solutions, brings body worn cameras (BWC) to a new level with innovative hardware and software design, convergence with push-to-talk technology, and integration with control room solution.
This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20210524005363/en/
Hytera has full series of 4G or LTE body worn cameras which can capture HD video to provide evidence for trials. More importantly, they are able to send live video back to the control center over 4G network. This helps the dispatcher know exactly what is happening, enhance real-time situational awareness and facilitate decision-making. Hytera has launched a comprehensive solution including the body worn camera, integrated device station and digital evidence management platform.
Designed for the field with evidence management in mind, the VM780 takes RVM Bodycams to the next level with the most advanced range of features available, including a 2.8” touch display, 3G/ 4G & Wi-Fi for real time transmission anywhere, GPS built-in and Push-to-talk over cellular (PoC) application compatibility. The device features a 216° rotatable camera and powerful 3-watt speaker to deliver loud and clear audio during the call, even in highly noisy environments. It also supports NFC and Bluetooth connectivity, AES256 advanced encryption technology, and simple charging and programming via the micro-USB interface.
The VM580D is suitable for both mission critical and commercial users. It’s slim (only 20mm thick), lightweight and easy to operate with one hand for photo taking, audio and video recording. It can share real-time GPS location information over LTE, 3G, and Wi-Fi networks. The device also serves as a PoC radio, which can be used for evidence collection simultaneously with a PoC platform such as Hytera HyTalk.
Hytera also provides various related software and hardware including storage, evidence collection, evidence classification, and dispatch platform, etc. Hytera is one of the few companies which can provide E2E body worn cameras solution to customers.
It's known to all that it is not uncommon for the officers to face the confrontations or dispute from the public during onsite law enforcement. Public safety and governmental institutions have increasingly advocated or legislated the use of BWC for promoting law enforcement transparency, deterring the violence and increasing trial efficiency. For example, a Dubai ruler issued a resolution to authorize its police to use security cameras in public areas to fulfill its duties including handling traffic violations and ensuring effective security. Hytera BWC Solution has been adopted by government and industry customers including the Shanghai Police and Macau Police to restore the truth of what happened with the first-person recording, voice and video, and bring better transparency and accountability to help improve law enforcement legitimacy.
Learn more at http://www.hytera.ae .
View source version on businesswire.com: https://www.businesswire.com/news/home/20210524005363/en/
Link:
Social Media:
About Business Wire
Subscribe to releases from Business Wire
Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.
Latest releases from Business Wire
Yamaha to Acquire Disguise, Expanding Its Capabilities in Integrated Audio, Video, Lighting and Media13.11.2026 08:00:00 CET | Press release
Acquisition combines Yamaha’s audio expertise with Disguise’s software and media server technologies Yamaha Corporation today announced an agreement to acquire Disguise Technologies Limited (“Disguise”), a London-based provider of software and media server technologies for live and immersive experiences. Yamaha will acquire the company by purchasing all shares in its parent, Butterfly Topco Limited. The acquisition will expand Yamaha’s capabilities beyond audio into integrated audio, video, lighting and media solutions, in line with its strategy to expand beyond hardware into software and services. By combining Yamaha’s audio expertise and global reach with Disguise’s software, technologies and worldwide partner network, the companies will be better positioned to deliver immersive experiences across live entertainment, sports and other venues. Disguise’s technology powers live and immersive experiences worldwide, including tours by Beyoncé and Taylor Swift and venues such as New York’s
Mexico Becomes the First Market Worldwide to Receive Approval for Galderma’s Restylane® Shaype™ for Both Chin and Its First Jawline Indication13.11.2026 07:00:00 CET | Press release
Restylane Shaype is now approved in Mexico for temporary augmentation in the chin area and improvement of jawline definition,1 with launch anticipated in H1 2027 Already approved across various markets globally for the chin area,2 this marks Restylane Shaype’s first approval for the jawline worldwide1 The first-and-only shaper on the hyaluronic acid (HA) market, Restylane Shaype features the firmest HA gel available and is powered by proprietary NASHA HD™ technology, developed to build and shape on bone for instant, natural-looking contour and definition3-6 The approval reinforces Galderma's commitment to advancing innovation in the HA category, enabling the company to meet diverse patient needs Galderma (SIX: GALD), the pure-play dermatology category leader, today announced that Restylane Shaype has been approved for temporary augmentation in the chin area and improvement of jawline definition in Mexico.1 This is the product’s first approval globally for the jawline, and further expan
vVARDIS Announces Pricing of Initial Public Offering13.11.2026 06:02:00 CET | Press release
vVARDIS Holding AG (“vVARDIS”), a Swiss healthcare company operating in the dental med-tech sector, today announced the pricing of its initial public offering of 9,722,223 Class A ordinary shares at a public offering price of $18.00 per share. In connection with the offering, vVARDIS has granted the underwriters a 30-day option to purchase up to an additional 1,458,333 Class A ordinary shares at the initial public offering price to cover over-allotments. The Class A ordinary shares are expected to begin trading on the New York Stock Exchange on November 13, 2026 under the symbol “VVVV.” The closing of the offering is expected to occur on or about November 16, 2026 subject to the satisfaction of customary closing conditions. Goldman Sachs & Co. LLC and J.P. Morgan are acting as joint bookrunning managers for the offering, with William Blair, UBS Investment Bank and Deutsche Bank Securities acting as bookrunners. A registration statement on Form F-1 relating to the offering has been file
Empire State Building Observation Deck to Debut ‘Olympus Awaits,’ An Immersive ‘Percy Jackson and the Olympians’ Takeover in the Heart of NYC, On Display from Nov. 16 – Dec. 4*12.11.2026 23:07:00 CET | Press release
The multi-level takeover includes a Throne Room, interactive photo opportunities, special lighting, and more The Empire State Building (ESB) is the gateway to Mount Olympus in Percy Jackson’s world, and now fans can experience the magic like never before. On Nov. 16, the Empire State Building Observation Deck (ESBOD) will unveil “Olympus Awaits,” a multi-level “Percy Jackson and the Olympians” takeover, in partnership with Disney+. The immersive takeover – included with every Observation Deck ticket – will feature an epic Throne Room, interactive photo opportunities, surprise giveaways, ESB x “Percy Jackson” merch, and more, available through Dec. 4, 2026.* This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20261112442266/en/ Empire State Building Observation Deck to Debut ‘Olympus Awaits,’ An Immersive ‘Percy Jackson and the Olympians’ Takeover in the Heart of NYC, On Display from Nov. 16 – Dec. 4* “This immersive NYC experience
Clene Nanomedicine Partners with Veristat to Reduce Biostatistical Output Time by 80% for ALS New Drug Application12.11.2026 18:09:00 CET | Press release
Veristat’s InStat™ delivers submission-ready tables, listings, and figures (TLFs) in one week using validated statistical engines, shortening the critical path from database lock to submission VeristatTM, a global clinical research organization (CRO) and consultancy specializing in complex studies, announced that it has partnered with Clene Nanomedicine to cut the time to deliver biostatistical outputs for a pivotal ALS drug application submission by 80%. Veristat reduced the time from study data to validated tables, listings and figures (TLFs) from up to six weeks to just one week. Clene, a late-stage biotech company, leveraged Veristat’s recently launched InStat™ platform, the industry’s first zero-code, fully automated solution to accelerate clinical trial processes. Biostatistical TLFs sit on the critical path for submissions, yet most sponsors rely on antiquated processes that involve slow, manual workflows to produce them, making post-database lock one of the biggest bottlenecks
In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.
Visit our pressroom